134 related articles for article (PubMed ID: 12168111)
1. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
[TBL] [Abstract][Full Text] [Related]
2. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
[TBL] [Abstract][Full Text] [Related]
3. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
[TBL] [Abstract][Full Text] [Related]
4. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett WP; Hollstein MC; Metcalf RA; Welsh JA; He A; Zhu SM; Kusters I; Resau JH; Trump BF; Lane DP
Cancer Res; 1992 Nov; 52(21):6092-7. PubMed ID: 1394236
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries.
Egashira A; Morita M; Kakeji Y; Sadanaga N; Oki E; Honbo T; Ohta M; Maehara Y
Cancer Sci; 2007 Aug; 98(8):1152-6. PubMed ID: 17573896
[TBL] [Abstract][Full Text] [Related]
7. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
8. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
[TBL] [Abstract][Full Text] [Related]
9. Pathology of esophageal cancers: local experience and current insights.
Lam KY; Ma L
Chin Med J (Engl); 1997 Jun; 110(6):459-64. PubMed ID: 9594248
[TBL] [Abstract][Full Text] [Related]
10. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
11. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
[TBL] [Abstract][Full Text] [Related]
16. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma.
Ribeiro U; Finkelstein SD; Safatle-Ribeiro AV; Landreneau RJ; Clarke MR; Bakker A; Swalsky PA; Gooding WE; Posner MC
Cancer; 1998 Jul; 83(1):7-18. PubMed ID: 9655287
[TBL] [Abstract][Full Text] [Related]
17. Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese.
Goan YG; Chang HC; Hsu HK; Chou YP; Cheng JT
Cancer Sci; 2005 Nov; 96(11):758-65. PubMed ID: 16271069
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of p53 gene mutation in esophageal exfoliative cells].
Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
[TBL] [Abstract][Full Text] [Related]
19. p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas.
Shahnavaz SA; Regezi JA; Bradley G; Dubé ID; Jordan RC
J Pathol; 2000 Mar; 190(4):417-22. PubMed ID: 10699989
[TBL] [Abstract][Full Text] [Related]
20. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran.
Biramijamal F; Allameh A; Mirbod P; Groene HJ; Koomagi R; Hollstein M
Cancer Res; 2001 Apr; 61(7):3119-23. PubMed ID: 11306496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
